Skip to content
Umoja Biopharma
  • Our Company
    • Leadership
    • Board of Directors
    • Advisory Board
    • Investors
  • Our Science
    • Overview
    • Manufacturing
  • Our Pipeline
  • News + Resources
    • Press Releases
    • Presentations + Publications
  • Careers
  • Contact
Umoja Biopharma
  • Our Company
  • Our Science
    • Overview
    • Manufacturing
  • Our Pipeline
  • News + Resources
    • Press Releases
    • Presentations
  • Careers
  • Contact
  • Accessibility
  • Privacy Policy
  • Transparency in Coverage
  • Sitemap

Press Releases

March 23, 2026
Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors

March 6, 2026
Umoja Biopharma Honors the Life and Legacy of Scientific Co-founder Dr. Philip Low

September 30, 2025
Umoja Biopharma Announces that UB-VV111 Receives FDA Fast Track Designation for Relapsed/Refractory B-Cell Malignancies

September 23, 2025
Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech

January 27, 2025
Umoja Biopharma Announces Appointment of Dr. Luke Walker as Chief Medical Officer

CONTACT US
Umoja Biopharma
  • Our Company
  • Our Science
  • Manufacturing
  • Our Pipeline
  • Careers
  • Press Releases
  • Presentations

1150 Eastlake Ave E,
Suite 400
Seattle, WA 98109
info@umoja-biopharma.com

  • Accessibility
  • Privacy Policy
  • Transparency in Coverage
  • Sitemap

© 2026 Umoja Biopharma. All rights reserved.